What does the Anti-VEGF Loading Dose procedure involve?

The procedure consists of three monthly intravitreal injections of either conbercept or a ranibizumab biosimilar. Each injection is performed in an outpatient setting under topical anesthesia, where a very fine needle delivers the medication into the vitreous cavity of the eye to inhibit abnormal blood vessel growth and leakage. The entire process takes about 15–20 minutes per visit, with no overnight stay required.